Most breast cancer is not genetic. Roughly 90% of cases arise from a combination of aging, lifestyle, and environmental factors rather than inherited gene mutations. Only 5% to 10% of breast cancers are caused by specific mutations passed down through families, most commonly in genes called BRCA1 and BRCA2. So while genetics can play a powerful role for some people, the majority of women diagnosed with breast cancer have no family history of the disease.
That said, the 5% to 10% that is hereditary carries significantly higher risk for those individuals, and knowing your family history can shape the screening and prevention choices available to you.
How Much Breast Cancer Is Hereditary
About 10% to 30% of breast cancer cases involve some hereditary component, meaning family history contributed to the person’s overall risk. But within that group, only 5% to 10% are driven by a clearly identifiable inherited mutation, the kind that shows up on a genetic test and follows a predictable pattern in families. The rest likely involve combinations of smaller genetic variations that individually raise risk only slightly.
The remaining 70% to 90% of cases are considered sporadic. These develop due to DNA damage that accumulates over a lifetime from things like aging, hormonal exposure, alcohol use, and other environmental factors. In other words, most breast cancer is not something you inherit. It’s something that develops.
The Genes That Matter Most
BRCA1 and BRCA2 are the two most well-known breast cancer genes. Women who carry a harmful mutation in either one have a greater than 60% chance of developing breast cancer during their lifetime, compared to about 13% for women in the general population. Men with these mutations face elevated risk too: up to about 7% for BRCA2 carriers by age 70, versus 0.1% in the general male population.
These mutations follow what’s called an autosomal dominant pattern. That means if one of your parents carries a BRCA1 or BRCA2 mutation, you have a 50% chance of inheriting it. It doesn’t matter whether the mutation comes from your mother or your father.
Beyond BRCA1 and BRCA2, several other genes raise breast cancer risk at moderate levels. Carriers of a PALB2 mutation face roughly a 50% chance of developing breast cancer by age 80. For CHEK2, that number is about 30%, and for ATM, about 28%. These genes are less commonly discussed, but they account for a meaningful share of hereditary cases that would go undetected if doctors only tested for BRCA mutations.
Non-Genetic Risk Factors
Since most breast cancer isn’t inherited, the factors that drive it are worth understanding. The two biggest risk factors are simply being female and getting older. Beyond that, several lifestyle and reproductive factors play a role:
- Physical inactivity raises breast cancer risk.
- Being overweight after menopause increases risk compared to maintaining a healthy weight.
- Alcohol consumption raises risk in proportion to how much you drink.
- Hormone replacement therapy combining estrogen and progesterone, taken for more than five years during menopause, increases risk.
- Reproductive history matters: having a first pregnancy after age 30, never breastfeeding, or never having a full-term pregnancy can all contribute.
- Smoking and exposure to certain environmental chemicals also appear to raise risk.
None of these factors alone is likely to cause breast cancer. Risk comes from the accumulation of multiple factors over time, which is why breast cancer becomes more common with age.
Signs Your Family History Warrants Genetic Testing
Genetic testing isn’t recommended for everyone. It’s most useful when your personal or family history suggests a hereditary pattern. The U.S. Preventive Services Task Force identifies several red flags that should prompt a conversation about testing:
- A first-degree relative (parent, sibling, child) with breast or ovarian cancer
- A family member diagnosed with breast cancer before age 50
- A male relative with breast cancer
- A family member who had both breast and ovarian cancer
- Bilateral breast cancer (cancer in both breasts) in a relative
- Two or more relatives with breast or ovarian cancer
- Ashkenazi Jewish ancestry
That last point matters because roughly 2% to 2.5% of Ashkenazi Jewish women carry one of three specific founding mutations in BRCA1 or BRCA2, a rate far higher than in the general population.
What Genetic Testing Looks Like Today
For years, genetic testing for breast cancer focused narrowly on BRCA1 and BRCA2. The problem was that many families with strong cancer histories tested negative for both, leaving them without answers. This “missing heritability” turned out to involve mutations in other genes that weren’t being checked.
Modern testing uses multigene panels that screen dozens of cancer-related genes simultaneously. This approach catches an additional 8% of breast cancer mutations that would be missed by BRCA-only testing, identifying changes in genes like CHEK2, ATM, PALB2, and TP53. The results can shape personalized prevention strategies based on the specific gene involved, since different mutations carry different risk levels and may call for different screening schedules.
Options for People With High-Risk Mutations
If genetic testing reveals a high-risk mutation, you have several paths forward. Enhanced screening is the most common first step: more frequent mammograms, breast MRIs starting at a younger age, or both. The goal is to catch any cancer as early as possible.
For those who want to reduce risk more aggressively, preventive (prophylactic) mastectomy lowers breast cancer risk by 85% to 100%. In one study with over six years of follow-up, breast cancer developed in fewer than 2% of women who had preventive surgery, compared to nearly 49% of matched controls who did not. This is a major decision, but for women facing a 60% or higher lifetime risk, the math can be compelling.
Risk also varies within families. If a known BRCA mutation runs in your family and you test negative for it, your risk drops significantly, though it doesn’t return to zero because you still carry the same non-genetic risk factors as everyone else. This is one of the most practical benefits of genetic testing: it can clarify risk for family members on both sides of the result.